<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Clinical manifestations and diagnosis of blastomycosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Clinical manifestations and diagnosis of blastomycosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Clinical manifestations and diagnosis of blastomycosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert W Bradsher, Jr, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carol A Kauffman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Milana Bogorodskaya, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 25, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blastomycosis is a systemic pyogranulomatous infection that arises after inhalation of the conidia of the thermally dimorphic fungus
         <em>
          Blastomyces dermatitidis
         </em>
         or
         <em>
          Blastomyces gilchristii
         </em>
         . Most cases of blastomycosis have been reported in North America.
        </p>
        <p>
         <em>
          Blastomyces
         </em>
         is a member of the family Ajellomycetaceae and order Onygenales. Fungal nomenclature has been changing based on multilocus phylogenetic analyses and sequencing, and
         <em>
          Blastomyces helicus, Blastomyces parvus, Blastomyces silverae, and Blastomyces percursus
         </em>
         have been placed in the genus
         <em>
          Blastomyces
         </em>
         rather than the genus
         <em>
          Emmonsia
         </em>
         [
         <a href="#rid1">
          1,2
         </a>
         ].
         <em>
          B. helicus
         </em>
         has been associated with disease in a small number of immunocompromised humans and domestic animals [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         The clinical manifestations and diagnosis of blastomycosis will be reviewed here. The mycology, pathogenesis, epidemiology, and treatment of blastomycosis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2458.html" rel="external">
          "Mycology, pathogenesis, and epidemiology of blastomycosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2463.html" rel="external">
          "Treatment of blastomycosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3164880385">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H987444542">
         <span class="h2">
          Spectrum of disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical manifestations of blastomycosis are varied and include asymptomatic infection, acute or chronic pneumonia, and extrapulmonary disease [
         <a href="#rid4">
          4
         </a>
         ]. Up to 50 percent of blastomycosis infections are asymptomatic [
         <a href="#rid5">
          5-9
         </a>
         ]. The incubation period from exposure until the onset of pulmonary symptoms is approximately three to six weeks [
         <a href="#rid6">
          6
         </a>
         ]. The incubation period from exposure to the onset of extrapulmonary symptoms is highly variable. Reactivation (both with pulmonary and extrapulmonary symptoms) can occur in immunocompromised patients (eg, individuals taking tumor necrosis factor (TNF)-alpha inhibitors or corticosteroids).
        </p>
        <p>
         Although blastomycosis has been reported to involve almost every organ, the lungs are the most common site of infection, followed by the skin, bones, and genitourinary system [
         <a href="#rid10">
          10,11
         </a>
         ]. As an example, in a study of 326 patients with blastomycosis, the following distribution of organ involvement was observed [
         <a href="#rid10">
          10
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pulmonary – 91 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Skin – 18 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bone – 4 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Genitourinary – 2 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Central nervous system (CNS) – 1 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other (laryngeal involvement, soft tissue, lymphatic, esophageal, joint, and tracheal involvement) – 3 percent
        </p>
        <p>
        </p>
        <p>
         In this study, 56 patients (17 percent) had multiorgan involvement, primarily involving either the lungs (95 percent) and/or the skin (77 percent).
        </p>
        <p>
         Extrapulmonary disease results from hematogenous spread from a primary pulmonary infection. Studies performed prior to the availability of effective therapy indicated that approximately two-thirds of patients with blastomycosis had multiorgan involvement [
         <a href="#rid12">
          12,13
         </a>
         ] and that the disease was progressive with reported mortality rates of up to 90 percent [
         <a href="#rid14">
          14
         </a>
         ]. However, most of these earlier studies were autopsy based; thus, multiorgan disease was probably overrepresented. Later reports in Arkansas [
         <a href="#rid15">
          15
         </a>
         ], Wisconsin [
         <a href="#rid16">
          16
         </a>
         ], Mississippi [
         <a href="#rid10">
          10
         </a>
         ], and Manitoba, Canada [
         <a href="#rid17">
          17
         </a>
         ] described a lower frequency of extrapulmonary disease.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Pulmonary involvement
         </span>
         <span class="headingEndMark">
          —
         </span>
         The lungs are the usual portal of entry for blastomycosis. Patients may present with either acute or chronic pneumonia, although chronic pneumonia is more common. Acute respiratory distress syndrome (ARDS) associated with blastomycosis has also been reported [
         <a href="#rid11">
          11,18
         </a>
         ].
        </p>
        <p>
         In a study that included 326 patients with blastomycosis, the following presenting symptoms were observed [
         <a href="#rid10">
          10
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cough – 73 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fever – 54 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sputum production – 50 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chest pain – 41 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Shortness of breath – 38 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Weight loss of at least 5 percent – 37 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Night sweats – 31 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chills – 28 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hemoptysis – 23 percent
        </p>
        <p>
        </p>
        <p>
         Other symptoms may include arthralgias, myalgias, and pleuritic chest pain.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Acute pneumonia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute infection is frequently unrecognized unless related to an epidemiologic cluster of cases. The signs and symptoms of acute pulmonary blastomycosis usually begin abruptly three to six weeks after infection and are often indistinguishable from viral or bacterial pneumonia [
         <a href="#rid4">
          4
         </a>
         ]. Occasionally, pneumonia may occur months to years after leaving the area of exposure [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         Patients with blastomycosis often have a history of pet dogs that are ill with pneumonia or have died from blastomycosis, suggesting that both humans and their pets have become infected by aerosol inhalation from the environment. Obtaining this history can be a valuable clue to the diagnosis of possible blastomycosis in a patient presenting with community-acquired pneumonia [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         Cough is initially nonproductive but often becomes productive of purulent sputum as the disease progresses. Patients may also experience fever, shortness of breath, weight loss, night sweats, and/or other pulmonary or constitutional signs and symptoms. (See
         <a class="local">
          'Pulmonary involvement'
         </a>
         above.)
        </p>
        <p>
         Laboratory findings are similar to those found in other forms of community-acquired pneumonia, such as leukocytosis and elevated inflammatory markers.
        </p>
        <p>
         Chest radiography most commonly reveals alveolar infiltrates or a mass lesion, although miliary or reticulonodular patterns can also occur [
         <a href="#rid21">
          21,22
         </a>
         ]. Chest computed tomography (CT) scanning may show nodules, consolidation with or without cavitation, and/or tree-in-bud opacities  (
         <a class="graphic graphic_diagnosticimage graphicRef83713" href="/z/d/graphic/83713.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef83714" href="/z/d/graphic/83714.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid23">
          23
         </a>
         ]. Small pleural effusions are frequent. The lack of significant hilar adenopathy may be helpful in distinguishing blastomycosis from histoplasmosis, in which adenopathy is common. (See
         <a class="medical medical_review" href="/z/d/html/2450.html" rel="external">
          "Pathogenesis and clinical features of pulmonary histoplasmosis"
         </a>
         .)
        </p>
        <p>
         Spontaneous resolution of acute pulmonary blastomycosis has been reported, but its frequency is unknown; patients with extrapulmonary manifestation often describe prior lung infection [
         <a href="#rid9">
          9,24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H210703334">
         <span class="h3">
          Acute respiratory distress syndrome (ARDS)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rarely, patients may present with diffuse pneumonitis associated with ARDS [
         <a href="#rid4">
          4,25-27
         </a>
         ]. In a series of 114 patients with blastomycosis from Indiana, ARDS was found in 17 percent [
         <a href="#rid11">
          11
         </a>
         ]. In a retrospective cohort study of 1848 patients hospitalized with blastomycosis, patients requiring mechanical ventilation (12 percent) had higher mortality compared with patients who did not require mechanical ventilation (40 versus 2.5 percent) [
         <a href="#rid28">
          28
         </a>
         ]. Mortality rates in mechanically ventilated patients were similar to mortality rates seen in patients with moderate to severe ARDS from all causes. In another small case series, the mortality rate associated with ARDS due to blastomycosis was over 50 percent [
         <a href="#rid25">
          25,26
         </a>
         ], and most deaths occurred during the first few days of treatment [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Chronic pneumonia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients diagnosed with blastomycosis may have a chronic pneumonia that is clinically similar to tuberculosis, other fungal infections (eg, histoplasmosis), or bronchogenic carcinoma [
         <a href="#rid4">
          4
         </a>
         ]. Diagnosis is often delayed for more than one month, even when patients seek medical attention within seven days of onset of illness, allowing patients to transition from acute to chronic pneumonia [
         <a href="#rid10">
          10
         </a>
         ]. Many of these patients receive multiple rounds of antibiotics before the diagnosis is established. Additionally, some patients are initially asymptomatic but progress over time into the chronic form of blastomycosis. Symptoms include low-grade fever, productive cough, hemoptysis, chest pain, and/or weight loss.
        </p>
        <p>
         Laboratory findings are nonspecific and may include leukocytosis, thrombocytosis, and elevated inflammatory markers (eg, erythrocyte sedimentation rate, C-reactive protein). However, many infected individuals may not have any laboratory abnormalities.
        </p>
        <p>
         The radiographic findings are varied. Alveolar infiltrates with or without cavitation, mass lesions, and fibronodular infiltrates are most common [
         <a href="#rid4">
          4,10
         </a>
         ]. Infiltrates are more frequently reported in the upper lobes. Small pleural effusions and pleural thickening have been reported, but large pleural effusions are uncommon. Significant pleural involvement was associated with a poor outcome in one series [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Extrapulmonary blastomycosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although extrapulmonary disease has been reported in over 50 percent of patients with chronic blastomycosis, most of these studies were autopsy based or were published prior to the availability of effective therapy [
         <a href="#rid12">
          12,13,30-34
         </a>
         ]. In contrast, more recent studies have documented multiorgan disease in approximately 20 percent of patients [
         <a href="#rid10">
          10,15-17
         </a>
         ]. Extrapulmonary disease can be seen with or without active pulmonary infection (usually chronic pneumonia) and in the absence of systemic symptoms (see
         <a class="local">
          'Spectrum of disease'
         </a>
         above). Many forms of extrapulmonary blastomycosis (bone, prostate, breast, thyroid) occur after the pulmonary infection has resolved and in the absence of systemic symptoms.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Skin
         </span>
         <span class="headingEndMark">
          —
         </span>
         Skin disease is the second most common manifestation of blastomycosis after pneumonia. The majority of cutaneous lesions are from hematogenous spread, and very few are from direct inoculation. Almost all purported inoculation infections are likely due to silent pulmonary infection followed by hematogenous spread [
         <a href="#rid4">
          4,35
         </a>
         ]. The mold form of
         <em>
          B. dermatitidis
         </em>
         that exists in the environment causes infection via inhalation with subsequent transformation of the organism in the respiratory tract to the yeast form, which is responsible for clinical disease. Trauma to the skin is known to precede discovery of bacterial [
         <a href="#rid36">
          36
         </a>
         ] or fungal [
         <a href="#rid37">
          37
         </a>
         ] infection that has spread hematogenously to the site of trauma, giving rise to the supposition that the organisms were directly inoculated.
        </p>
        <p>
         The characteristic cutaneous finding is a verrucous lesion, with irregular borders  (
         <a class="graphic graphic_picture graphicRef83716" href="/z/d/graphic/83716.html" rel="external">
          picture 2
         </a>
         and
         <a class="graphic graphic_picture graphicRef83720" href="/z/d/graphic/83720.html" rel="external">
          picture 3
         </a>
         and
         <a class="graphic graphic_picture graphicRef83721" href="/z/d/graphic/83721.html" rel="external">
          picture 4
         </a>
         ). The color may range from gray to violet. This lesion may mimic squamous cell carcinoma. Microabscesses form at the periphery of verrucous lesions, and biopsies taken from the margins usually reveal broad-based budding organisms on microscopy. Ulcerative lesions that bleed easily and have well-demarcated, heaped-up borders may also occur  (
         <a class="graphic graphic_picture graphicRef83717" href="/z/d/graphic/83717.html" rel="external">
          picture 5
         </a>
         and
         <a class="graphic graphic_picture graphicRef83718" href="/z/d/graphic/83718.html" rel="external">
          picture 6
         </a>
         ) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         Subcutaneous nodules are cold abscesses that can be seen in patients with disseminated disease  (
         <a class="graphic graphic_picture graphicRef83719" href="/z/d/graphic/83719.html" rel="external">
          picture 7
         </a>
         ). Microscopic examination from these lesions reveals broad-based budding yeasts typical of
         <em>
          Blastomyces
         </em>
         (
         <a class="graphic graphic_picture graphicRef63105" href="/z/d/graphic/63105.html" rel="external">
          picture 8
         </a>
         and
         <a class="graphic graphic_picture graphicRef66379" href="/z/d/graphic/66379.html" rel="external">
          picture 9
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Bone and joint
         </span>
         <span class="headingEndMark">
          —
         </span>
         Osteomyelitis is the next most common extrapulmonary manifestation of blastomycosis after cutaneous involvement, occurring in up to one-quarter of cases of patients with multiorgan disease [
         <a href="#rid38">
          38
         </a>
         ]. A retrospective study of 45 patients hospitalized with blastomycosis of the bones or joints revealed that cutaneous disease was present in 33 (73 percent) and pulmonary disease in 29 (64 percent) [
         <a href="#rid39">
          39
         </a>
         ]. This study is consistent with results from the University of Mississippi Medical Center, in which patients with isolated skin disease were at risk for infection in other nonpulmonary sites [
         <a href="#rid10">
          10
         </a>
         ]. Any bone may be involved, although the most common are the vertebrae, pelvis, and sacrum [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         Patients often present with soft tissue swelling or a chronic draining sinus tract adjacent to the focus of osteomyelitis [
         <a href="#rid4">
          4
         </a>
         ]. There is usually little or no bone pain associated with osteomyelitis due to blastomycosis.
        </p>
        <p>
         A well-circumscribed, osteolytic lesion is the most common radiographic finding. Vertebral disease can be radiographically similar to tuberculosis, with anterior involvement of the vertebral body and destruction of the disc interspace [
         <a href="#rid40">
          40
         </a>
         ]. Paravertebral abscesses are also commonly associated with vertebral blastomycosis [
         <a href="#rid41">
          41
         </a>
         ]. Biopsy of bone lesions caused by
         <em>
          Blastomyces dermatitidis
         </em>
         may reveal granuloma formation, suppuration, and/or necrosis [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         Arthritis due to blastomycosis usually results from direct extension from osteomyelitis and may be acute or chronic in its presentation.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Genitourinary system
         </span>
         <span class="headingEndMark">
          —
         </span>
         Extrapulmonary blastomycosis occurs more commonly in men; genitourinary system involvement presents as prostatitis and epididymoorchitis [
         <a href="#rid42">
          42,43
         </a>
         ]. Some patients have asymptomatic pyuria. Urine cultures are more likely to be positive if specimens are obtained after prostatic massage and the sediment is cultured after centrifugation.
        </p>
        <p>
         Rare cases of tuboovarian abscess or endometritis have been reported in women [
         <a href="#rid44">
          44
         </a>
         ]. In one case report, a woman acquired blastomycosis by sexual transmission from a man who had disseminated disease [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Central nervous system (CNS)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blastomycosis of the CNS is uncommon in immunocompetent hosts and has been reported in fewer than 5 percent of cases. CNS involvement may occur in immunocompromised patients, especially those with acquired immunodeficiency syndrome (AIDS) [
         <a href="#rid45">
          45
         </a>
         ]. In a retrospective study of patients with human immunodeficiency virus (HIV) and blastomycosis, 6 of 15 had CNS involvement, usually manifested as single or multiple brain abscesses [
         <a href="#rid45">
          45
         </a>
         ]. However, in another review, 10 of 22 patients with CNS blastomycosis were not considered to be immunosuppressed [
         <a href="#rid46">
          46
         </a>
         ]. Of note, 17 of the 22 patients had evidence of blastomycosis in other organs as well.
        </p>
        <p>
         CNS infection may present as meningitis, epidural abscess, or intracranial abscesses, particularly in the cerebellum [
         <a href="#rid46">
          46
         </a>
         ]. If meningitis is present, cerebrospinal fluid (CSF) analysis typically shows lymphocytic pleocytosis with elevated protein and low glucose.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Other sites
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          B. dermatitidis
         </em>
         has been reported to involve almost every organ, including lymph nodes, liver, spleen, breast, adrenal gland, thyroid, and eye [
         <a href="#rid4">
          4
         </a>
         ]. Blastomycosis has also been reported in the mucosa of the nose, mouth, and larynx.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Special populations
         </span>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h3">
          Children
         </span>
         <span class="headingEndMark">
          —
         </span>
         An estimated 10 percent of patients reported with blastomycosis are children [
         <a href="#rid5">
          5,17,47
         </a>
         ]. The clinical spectrum in pediatric disease is similar to that in adults.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Pregnancy and perinatal transmission
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blastomycosis has been reported, albeit infrequently, during pregnancy. Pregnant women are more likely to have disseminated disease than nonpregnant individuals; this may be related to the depressed cellular immunity associated with pregnancy [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
         Perinatal transmission has been documented. Infection may result from aspiration of infected vaginal secretions during childbirth [
         <a href="#rid49">
          49
         </a>
         ], an ascending vaginal infection associated with premature rupture of the membranes, or transplacental infection.
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h3">
          Immunocompromised hosts
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Blastomyces
         </em>
         can behave as an opportunistic pathogen, especially in patients with AIDS, transplant recipients, those who are taking certain immunocompromising agents (eg, glucocorticoids, TNF-alpha inhibitors), and other immunocompromised patients [
         <a href="#rid4">
          4,50-52
         </a>
         ]. Pulmonary disease tends to be more severe in immunocompromised hosts, including higher mortality rates and findings of diffuse pulmonary infiltrates, large pleural effusions, and/or respiratory failure. As an example, in a retrospective review of 106 patients, those who were immunocompromised had more severe infections, higher rates of respiratory failure, and higher mortality rates compared with immunocompetent patients [
         <a href="#rid53">
          53
         </a>
         ]. In contrast to other endemic mycoses (eg, histoplasmosis, coccidioidomycosis), immunosuppression has not been associated with increased risk of dissemination in blastomycosis. These findings suggest that pathogen-related factors may play a larger role in risk of dissemination than the immune status of the host [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         Frequent relapses have been reported in patients with AIDS and in patients who remain on immunosuppressive therapy. This is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2463.html" rel="external">
          "Treatment of blastomycosis", section on 'Immunocompromised patients'
         </a>
         .)
        </p>
        <p>
         Infection with
         <em>
          B. helicus
         </em>
         has been described in a small number of humans in western Canada and western United States [
         <a href="#rid3">
          3
         </a>
         ]. In this report, six of the seven patients with available clinical data had immunocompromising conditions, including HIV/AIDS, liver transplantation, lupus erythematosus, chronic leukemia with use of corticosteroids, and diabetes mellitus with concurrent alcoholism [
         <a href="#rid3">
          3
         </a>
         ]. The organism was isolated in cultures of blood, CSF, and/or bronchoalveolar fluid, and only two of the seven patients survived.
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H748629539">
         <span class="h2">
          When to suspect blastomycosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Timely diagnosis of blastomycosis warrants a high index of clinical suspicion, since the infection is uncommon and not easily diagnosed with routine culture methods. Blastomycosis should be suspected in a patient who resides in or has recently traveled (within the last 2 to 3 years) to a
         <em>
          Blastomyces
         </em>
         -endemic area and has at least one of the following features [
         <a href="#rid54">
          54
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Community-acquired pneumonia of unknown etiology that has not responded to a course of empiric antibiotics
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Community-acquired pneumonia with associated skin lesions
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Characteristic skin lesions  (
         <a class="graphic graphic_picture graphicRef83716" href="/z/d/graphic/83716.html" rel="external">
          picture 2
         </a>
         and
         <a class="graphic graphic_picture graphicRef83720" href="/z/d/graphic/83720.html" rel="external">
          picture 3
         </a>
         and
         <a class="graphic graphic_picture graphicRef83721" href="/z/d/graphic/83721.html" rel="external">
          picture 4
         </a>
         and
         <a class="graphic graphic_picture graphicRef83717" href="/z/d/graphic/83717.html" rel="external">
          picture 5
         </a>
         and
         <a class="graphic graphic_picture graphicRef83718" href="/z/d/graphic/83718.html" rel="external">
          picture 6
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clinical manifestations consistent with extrapulmonary blastomycosis (eg, osteomyelitis, epididymitis, prostatitis, brain abscess) with negative bacterial cultures and no response to initial treatment
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Radiographic pulmonary and/or bone findings concerning for malignancy, mycobacterial infections (including tuberculosis), or other endemic infections (eg, histoplasmosis, coccidioidomycosis)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Presence of granulomas with neutrophilic predominance on histopathology
        </p>
        <p>
        </p>
        <p>
         Presence of additional risk factors, such as engaging in outdoor activities (eg, fishing, hunting, canoeing, rafting, composting), exposure to home remodeling or construction sites, or cutting and stacking wood, should increase the index of clinical suspicion for blastomycosis.
        </p>
        <p>
         Diagnosis of blastomycosis is often delayed. In one survey, infectious diseases physicians reported more than a one-month delay in diagnosis in 40 percent of endemic mycosis cases; the delay in diagnosis had a moderate or major impact on clinical care in 66 percent of cases [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3298471901">
         <span class="h2">
          Approach to diagnosis
         </span>
        </p>
        <p class="headingAnchor" id="H3382879953">
         <span class="h3">
          Initial testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         When blastomycosis is suspected, we send urine antigen as well as any available respiratory specimens (eg, sputum, bronchoalveolar lavage [BAL] fluid) and/or other aspirated material or tissue collected from biopsy for direct microscopy, fungal culture, and histopathology [
         <a href="#rid54">
          54
         </a>
         ]. We ask the microbiology laboratory to incubate the culture for six weeks to allow for fungal growth and alert them to our suspicion for blastomycosis so laboratory staff can take appropriate precautions when handling the specimens. Some contributors also send a serum antigen at the same time as the urine antigen to increase the sensitivity of the tests, especially in patients who are critically ill.
        </p>
        <p>
         In patients who are not producing sputum or in whom lung imaging indicates the possibility of malignancy, bronchoscopy is particularly useful [
         <a href="#rid56">
          56
         </a>
         ]. Bronchial washings, BAL fluid, and postbronchoscopy sputum samples should be sent for cytology and fungal staining and culture; the organism is often visualized on Papanicolaou preparations [
         <a href="#rid57">
          57
         </a>
         ]. When available, samples can also be sent for polymerase chain reaction (PCR) and antigen testing.
        </p>
        <p>
         For patients suspected of having central nervous system (CNS) blastomycosis, we perform a lumbar puncture and send cerebrospinal fluid (CSF) for fungal culture/staining as well as antigen testing. Although the sensitivity of antigen testing in the CSF is low, a positive result is helpful in supporting the diagnosis of CNS blastomycosis.
        </p>
        <p>
         Serology assays have low sensitivity and specificity and are not recommended for diagnostic purposes.
        </p>
        <p class="headingAnchor" id="H2441861111">
         <span class="h3">
          Establishing a diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Definitive diagnosis requires growth or visualization of the organism from a clinical specimen [
         <a href="#rid4">
          4
         </a>
         ]. Unlike
         <em>
          Candida
         </em>
         and
         <em>
          Aspergillus
         </em>
         spp, colonization or contamination with
         <em>
          Blastomyces
         </em>
         does not occur, which means that visualizing the organism or obtaining a positive culture confirms the diagnosis of blastomycosis. Visualization of broad-based budding yeasts on direct microscopy is the most rapid way to make a presumptive diagnosis of blastomycosis, as growth on culture often takes up to four weeks.
        </p>
        <p>
         In the appropriate clinical situation (eg, acute respiratory distress syndrome [ARDS] or rapid clinical worsening in a patient), a positive urine antigen test may justify beginning empirical antifungal therapy. Although urine antigens have a high sensitivity (80-95 percent), they are sent out to other laboratories, prolonging the turn-around time for results, and have a lower specificity due to cross-reactivity with other endemic mycoses, especially histoplasmosis. For patients in whom histoplasmosis is also on the differential, identification of
         <em>
          Blastomyces
         </em>
         spp by histology or culture is necessary to make the correct diagnosis. Since the initial treatment for histoplasmosis and blastomycosis is similar, treatment that is initiated while awaiting confirmatory results will treat both infections. (See
         <a class="medical medical_review" href="/z/d/html/2463.html" rel="external">
          "Treatment of blastomycosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H947576664">
         <span class="h2">
          Diagnostic tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic tests for blastomycosis include fungal culture, visualization of
         <em>
          Blastomyces
         </em>
         spp on direct microscopy or histopathology, antigen testing, molecular methods, and serology. Details of each testing modality is discussed below.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Culture
         </strong>
         – Identification of
         <em>
          Blastomyces
         </em>
         spp by culture depends upon growth of the organism in the mycelial phase at room temperature and then sending the isolate to a reference laboratory for definitive identification [
         <a href="#rid58">
          58
         </a>
         ]. The mold form of the organism is not difficult to culture from most clinical specimens using fungal media (Sabouraud dextrose agar and potato dextrose agar) at 25 to 30°C; it typically grows within one to four weeks [
         <a href="#rid4">
          4
         </a>
         ]. Confirmation of the identity of
         <em>
          Blastomyces
         </em>
         is now done with mass spectrometry (MALDI-TOF). The mycelial phase produces spherical, oval, or pyriform conidia from aerial hyphae. At 37°C,
         <em>
          B. dermatitidis
         </em>
         colonies are wrinkled, pasty, and moist. The yeast cell, whether in vitro or in tissue, is thick walled and spherical, producing single buds with a broad base of attachment between the bud and parent cell  (
         <a class="graphic graphic_picture graphicRef66379" href="/z/d/graphic/66379.html" rel="external">
          picture 9
         </a>
         and
         <a class="graphic graphic_picture graphicRef63105" href="/z/d/graphic/63105.html" rel="external">
          picture 8
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         In adult patients with pulmonary blastomycosis, sputum culture has a high yield (75 percent per single sample, 86 percent per patient) [
         <a href="#rid56">
          56
         </a>
         ]. Specimens obtained for culture by bronchoscopy yield a positive diagnosis in 92 percent of patients.
        </p>
        <p>
         CSF culture has a lower yield of around 45 percent [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Direct
         </strong>
         <strong>
          microscopy
         </strong>
         – Although wet preparations have a relatively low diagnostic yield (36 percent for a single specimen and 46 percent for multiple specimens) [
         <a href="#rid56">
          56
         </a>
         ], the simplicity and low cost of the procedure, as well as its potential for rapid presumptive diagnosis, justify a wet preparation on all clinical specimens.
        </p>
        <p>
        </p>
        <p>
         Fresh wet preparations of sputum, pleural fluid, BAL fluid, CSF, urine, purulent material, skin scrapings, or tissue impression smears may be examined directly with calcofluor white, 10 percent potassium hydroxide (KOH), or both. KOH has been recommended to lyse mammalian cells, which aids in finding yeast and fungal elements, but most laboratories have supplanted this with calcofluor white, which causes the yeast cell wall to fluoresce. Calcofluor white staining requires use of a fluorescence microscope but is easy, rapid, and particularly useful when organisms are sparse.
        </p>
        <p>
         It is useful to concentrate clinical specimens, such as sputum, urine, pleural fluid, and CSF by centrifugation. It is also helpful to digest sputum samples with trypsin and smear the centrifuged sediment.
        </p>
        <p>
         When visualized, the yeast cells are easily differentiated from others on the basis of their size (8 to 15 microns in diameter), refractile cell wall, and single, broad-based buds  (
         <a class="graphic graphic_picture graphicRef66379" href="/z/d/graphic/66379.html" rel="external">
          picture 9
         </a>
         and
         <a class="graphic graphic_picture graphicRef63105" href="/z/d/graphic/63105.html" rel="external">
          picture 8
         </a>
         and
         <a class="graphic graphic_picture graphicRef62300" href="/z/d/graphic/62300.html" rel="external">
          picture 10
         </a>
         ). Occasionally, the endospores of
         <em>
          Coccidioides
         </em>
         species may resemble single yeast cells, but the presence of broad-based budding yeasts can be used to distinguish
         <em>
          Blastomyces
         </em>
         .
         <em>
          Paracoccidioides brasiliensis
         </em>
         , rarely seen in the United States, is distinguished from
         <em>
          Blastomyces
         </em>
         by the presence of multiple, narrow-based buds arranged around the periphery of the mother cell.
         <em>
          Blastomyces
         </em>
         may sometimes be as small as
         <em>
          Cryptococcus neoformans
         </em>
         , although the capsule and narrow-based bud of the latter aid in differentiation. (See
         <a class="medical medical_review" href="/z/d/html/2420.html" rel="external">
          "Coccidioidomycosis: Laboratory diagnosis and screening"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2435.html" rel="external">
          "Clinical manifestations and diagnosis of chronic paracoccidioidomycosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2448.html" rel="external">
          "Microbiology and epidemiology of Cryptococcus neoformans infection"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Histopathology
         </strong>
         – A pyogranulomatous tissue response is frequently seen in blastomycosis and should signal the possibility of this fungus. Yeast forms may be difficult to visualize with routine hematoxylin and eosin stains and are much better visualized on special stains, such as the methenamine silver stain or the periodic acid-Schiff stain  (
         <a class="graphic graphic_picture graphicRef83714" href="/z/d/graphic/83714.html" rel="external">
          picture 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antigen testing
         </strong>
         – An antigen detection assay for blastomycosis is currently available for clinical use [
         <a href="#rid59">
          59,60
         </a>
         ]. The sensitivity of this assay is 89 percent in disseminated blastomycosis and 93 percent overall. Sensitivity is higher in urine than in serum. However, specificity is around 79 percent due to cross-reactivity with antigens present in histoplasmosis, coccidioidomycosis, paracoccidioidomycosis, and talaromycosis [
         <a href="#rid61">
          61
         </a>
         ]. Cross-reactivity was less than 5 percent for patients with aspergillosis or cryptococcosis and less than 2 percent in healthy adults [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Antigen detection in the CSF can also be used to diagnose CNS blastomycosis, although interpretation is difficult as test characteristics have not been fully elucidated for these specimens [
         <a href="#rid46">
          46,62
         </a>
         ]. Antigen detection can be used on BAL fluid, but sensitivity and specificity have not been defined.
        </p>
        <p>
         Antigen levels appear to decline with successful treatment and increase with recurrence of illness [
         <a href="#rid63">
          63,64
         </a>
         ]. In one review, 23 of 27 patients (85 percent) with recently diagnosed blastomycosis had antigenuria detected, while none of 50 control subjects had
         <em>
          B. dermatitidis
         </em>
         antigenuria [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Molecular testing
         </strong>
         – Molecular testing (eg, PCR) exists and is increasingly being used for the diagnosis of severe pulmonary blastomycosis. Molecular testing is becoming more available but has not been evaluated for diagnostic purposes in large studies [
         <a href="#rid66">
          66,67
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Molecular identification of
         <em>
          B. dermatitidis
         </em>
         has been accomplished by a variety of techniques, including PCR assays for ribosomal genes [
         <a href="#rid68">
          68,69
         </a>
         ], the ITS-region [
         <a href="#rid68">
          68
         </a>
         ], repetitive sequences [
         <a href="#rid69">
          69
         </a>
         ], and species- or genus-specific genes [
         <a href="#rid70">
          70,71
         </a>
         ]. In addition, real-time PCR assays that can identify
         <em>
          B. dermatitidis
         </em>
         in culture specimens, in various clinical specimens (eg, bronchial washings, bronchoalveolar fluid, pleural fluid, sputum, blood), and in paraffin-embedded tissue have been developed [
         <a href="#rid66">
          66,72
         </a>
         ]. A number of case reports have used detection of
         <em>
          B. dermatitidis
         </em>
         deoxyribonucleic acid (DNA) in histology tissue blocks to confirm the diagnosis of blastomycosis as this technique has become increasingly available [
         <a href="#rid73">
          73,74
         </a>
         ]. However, PCR techniques are labor intensive, and although promising, the sensitivity and specificity of these tests on various specimens have not been defined, and their utility has not been confirmed in large prospective studies.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Serology
         </strong>
         – Serologic testing is not useful for the diagnosis of blastomycosis [
         <a href="#rid59">
          59
         </a>
         ], owing to the high degree of cross-reactivity shared by the endemic mycoses, most notably
         <em>
          Histoplasma capsulatum
         </em>
         . Immunodiffusion assays that measure antibody to
         <em>
          Blastomyces dermatitidis
         </em>
         A antigen are relatively specific, but sensitivity is only 28 to 64 percent [
         <a href="#rid75">
          75,76
         </a>
         ]. Complement fixation tests perform even less well, with sensitivities of 9 to 43 percent and poor specificity [
         <a href="#rid75">
          75,76
         </a>
         ]. Enzyme immunoassays employing A antigen are the least reliable, with greater sensitivity but lower specificity compared with other methods [
         <a href="#rid75">
          75-78
         </a>
         ]. Serologic studies using yeast phase lysates from multiple sources of
         <em>
          B. dermatitidis
         </em>
         have been explored for immunoglobin (Ig) M and IgG antibody detection in an effort to improve immunodiagnostic testing for blastomycosis [
         <a href="#rid79">
          79,80
         </a>
         ]. This test is available only from the reference laboratory (MiraVista, Indianapolis, IN) that developed the assay. Although these tests are promising, they have not been validated using human specimens. A study of patients with blastomycosis reported 88 percent sensitivity of an enzyme immunoassay employing the BAD1 surface protein of
         <em>
          B. dermatitidis
         </em>
         [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1126427252">
         <span class="h2">
          Postdiagnostic evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         We obtain a chest radiograph in all patients diagnosed with blastomycosis, even if no evidence of lung involvement is present [
         <a href="#rid82">
          82
         </a>
         ]. We also obtain a urine antigen level if one has not yet been obtained, as it sometimes can help in assessing treatment response. Additionally, in patients presenting with neurological signs or symptoms (eg, headache, paresthesias), we obtain magnetic resonance imaging (MRI) of the brain with contrast and a lumbar puncture to evaluate for CNS involvement.
        </p>
        <p class="headingAnchor" id="H805588757">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both acute and chronic blastomycosis may mimic other diseases [
         <a href="#rid50">
          50,83
         </a>
         ]. This is due to the variability of the presentation of blastomycosis and its relative rarity. Epidemiologic clues in the patient's history may help in differentiating blastomycosis from the other conditions, but culture and histopathology evaluation are necessary for diagnosis.
        </p>
        <p>
         The differential diagnosis depends on the patient's geographic location and travel history, the clinical presentation, and which organ systems are involved:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute pulmonary blastomycosis is often initially misdiagnosed as community-acquired bacterial or viral pneumonia. Nonresolving pneumonia that does not respond to a course of empiric antibiotics should prompt suspicion for endemic mycoses, such as blastomycosis, in patients who reside in or have traveled to an endemic area.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic pulmonary blastomycosis is often initially thought to be malignancy or tuberculosis. It can also present similarly to chronic noninfectious pneumonias (eg, cryptogenic organizing pneumonia), other nontuberculous mycobacterial pulmonary infections, or other endemic fungal infections (eg, histoplasmosis, coccidioidomycosis). Blastomycosis is more likely to have skin involvement compared with other similar infections or noninfectious causes. Unlike histoplasmosis, blastomycosis rarely presents with hilar adenopathy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Skin lesions caused by blastomycosis are frequently misdiagnosed as keratoacanthoma, pyoderma gangrenosum, or squamous cell carcinoma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Osseous blastomycosis is often initially thought to be tuberculosis or malignancy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Involvement of other areas of the body (eg, larynx, brain, lymph nodes) may be misdiagnosed initially as malignancy.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Spectrum of disease
         </strong>
         – The clinical manifestations of blastomycosis are varied and include asymptomatic infection, acute or chronic pneumonia, and extrapulmonary disease. Although blastomycosis has been reported to involve almost every organ, the lungs are the most common site. (See
         <a class="local">
          'Spectrum of disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Most patients present with chronic pneumonia. Skin disease is the second most common manifestation and is characterized by verrucous lesions  (
         <a class="graphic graphic_picture graphicRef83716" href="/z/d/graphic/83716.html" rel="external">
          picture 2
         </a>
         and
         <a class="graphic graphic_picture graphicRef83720" href="/z/d/graphic/83720.html" rel="external">
          picture 3
         </a>
         and
         <a class="graphic graphic_picture graphicRef83721" href="/z/d/graphic/83721.html" rel="external">
          picture 4
         </a>
         ), ulcerative lesions  (
         <a class="graphic graphic_picture graphicRef83717" href="/z/d/graphic/83717.html" rel="external">
          picture 5
         </a>
         and
         <a class="graphic graphic_picture graphicRef83718" href="/z/d/graphic/83718.html" rel="external">
          picture 6
         </a>
         ), or subcutaneous nodules  (
         <a class="graphic graphic_picture graphicRef83719" href="/z/d/graphic/83719.html" rel="external">
          picture 7
         </a>
         ). Osteomyelitis is the next most common extrapulmonary manifestation. (See
         <a class="local">
          'Chronic pneumonia'
         </a>
         above and
         <a class="local">
          'Skin'
         </a>
         above and
         <a class="local">
          'Bone and joint'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          When to suspect blastomycosis
         </strong>
         – Blastomycosis should be suspected in a patient who resides in or has recently traveled (within the last 2 to 3 years) to a
         <em>
          Blastomyces
         </em>
         -endemic area and has at least one of the following features [
         <a href="#rid54">
          54
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Community-acquired pneumonia of unknown etiology that has not responded to a course of empiric antibiotics
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Community-acquired pneumonia with associated skin lesions
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Characteristic skin lesions  (
         <a class="graphic graphic_picture graphicRef83716" href="/z/d/graphic/83716.html" rel="external">
          picture 2
         </a>
         and
         <a class="graphic graphic_picture graphicRef83720" href="/z/d/graphic/83720.html" rel="external">
          picture 3
         </a>
         and
         <a class="graphic graphic_picture graphicRef83721" href="/z/d/graphic/83721.html" rel="external">
          picture 4
         </a>
         and
         <a class="graphic graphic_picture graphicRef83717" href="/z/d/graphic/83717.html" rel="external">
          picture 5
         </a>
         and
         <a class="graphic graphic_picture graphicRef83718" href="/z/d/graphic/83718.html" rel="external">
          picture 6
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Clinical manifestations consistent with extrapulmonary blastomycosis (eg, osteomyelitis, epididymitis, prostatitis, brain abscess) with negative bacterial cultures and no response to initial treatment
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Radiographic pulmonary and/or bone findings concerning for malignancy, mycobacterial infections (including tuberculosis), or other endemic infections (eg, histoplasmosis, coccidioidomycosis)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Presence of granulomas with neutrophilic predominance on histopathology (see
         <a class="local">
          'When to suspect blastomycosis'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial testing
         </strong>
         – When blastomycosis is suspected, we send urine antigen as well as any available respiratory specimens (eg, sputum, bronchoalveolar lavage [BAL] fluid) and/or other aspirated material or tissue collected from biopsy for direct microscopy, fungal culture, and histopathology. (See
         <a class="local">
          'Initial testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Establishing the diagnosis
         </strong>
         – Definitive diagnosis requires growth or visualization of the organism from a clinical specimen. If the patient is critically ill and the clinical picture is consistent with blastomycosis, a positive urine antigen test may justify beginning empirical antifungal therapy. (See
         <a class="local">
          'Establishing a diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postdiagnostic evaluation
         </strong>
         – We obtain a chest radiograph and a baseline urine antigen level in all patients diagnosed with blastomycosis. In patients presenting with neurological signs or symptoms (eg, headache, paresthesias), we obtain an MRI of the brain with contrast and a lumbar puncture to evaluate for central nervous system (CNS) involvement. (See
         <a class="local">
          'Postdiagnostic evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – Both acute and chronic blastomycosis often mimic other diseases. Acute pulmonary blastomycosis may be initially diagnosed as community-acquired bacterial or viral pneumonia, whereas chronic pulmonary blastomycosis is most often thought to be malignancy or tuberculosis. Acute infection is frequently unrecognized unless related to a cluster of cases. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Dukik K, Muñoz JF, Jiang Y, et al. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses 2017; 60:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang Y, Dukik K, Munoz J, et al. Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis. Fungal Diversity 2018; 90:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz IS, Wiederhold NP, Hanson KE, et al. Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States. Clin Infect Dis 2019; 68:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 2010; 23:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein BS, Vergeront JM, DiSalvo AF, et al. Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. Am Rev Respir Dis 1987; 136:1333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein BS, Vergeront JM, Davis JP. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect 1986; 1:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Proctor ME, Klein BS, Jones JM, Davis JP. Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation. Mycopathologia 2002; 153:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein BS, Vergeront JM, Weeks RJ, et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986; 314:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaaler AK, Bradsher RW, Davies SF. Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin. Am J Med 1990; 89:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chapman SW, Lin AC, Hendricks KA, et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect 1997; 12:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azar MM, Assi R, Relich RF, et al. Blastomycosis in Indiana: Clinical and Epidemiologic Patterns of Disease Gleaned from a Multicenter Retrospective Study. Chest 2015; 148:1276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           KAPLAN W, CLIFFORD MK. BLASTOMYCOSIS. I. A REVIEW OF 198 COLLECTED CASES IN VETERANS ADMINISTRATION HOSPITALS. Am Rev Respir Dis 1964; 89:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Witorsch P, Utz JP. North American blastomycosis: a study of 40 patients. Medicine (Baltimore) 1968; 47:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin, DS, Smith, DT. Blastomycosis I: A review of the literature. Am Rev Tuberc 1939; 39:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradsher RW, Rice DC, Abernathy RS. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 1985; 103:872.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baumgardner DJ, Buggy BP, Mattson BJ, et al. Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin. Clin Infect Dis 1992; 15:629.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crampton TL, Light RB, Berg GM, et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. Clin Infect Dis 2002; 34:1310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansour MK, Ackman JB, Branda JA, Kradin RL. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 32-2015. A 57-Year-Old Man with Severe Pneumonia and Hypoxemic Respiratory Failure. N Engl J Med 2015; 373:1554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ogura Y, Yaguchi T, Kasamatsu Y, et al. First Japanese case of disseminated blastomycosis imported from North America: A case report. J Infect Chemother 2023; 29:988.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarosi GA, Eckman MR, Davies SF, Laskey WK. Canine blastomycosis as a harbinger of human disease. Ann Intern Med 1979; 91:733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheflin JR, Campbell JA, Thompson GP. Pulmonary blastomycosis: findings on chest radiographs in 63 patients. AJR Am J Roentgenol 1990; 154:1177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown LR, Swensen SJ, Van Scoy RE, et al. Roentgenologic features of pulmonary blastomycosis. Mayo Clin Proc 1991; 66:29.
          </a>
         </li>
         <li class="breakAll">
          Fungal and parasitic infection. In: Imaging of Pulmonary Infections, Muller NL, Franquet T, Soo Lee K (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007. p.115.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarosi GA, Davies SF, Phillips JR. Self-limited blastomycosis: a report of 39 cases. Semin Respir Infect 1986; 1:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 1993; 329:1231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemos LB, Baliga M, Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol 2001; 5:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lahm T, Neese S, Thornburg AT, et al. Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature. Chest 2008; 133:1478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rush B, Lother S, Paunovic B, et al. Outcomes With Severe Blastomycosis and Respiratory Failure in the United States. Clin Infect Dis 2021; 72:1603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kinasewitz GT, Penn RL, George RB. The spectrum and significance of pleural disease in blastomycosis. Chest 1984; 86:580.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           CHERNISS EI, WAISBREN BA. North American blastomycosis: a clinical study of 40 cases. Ann Intern Med 1956; 44:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ABERNATHY RS. Clinical manifestations of pulmonary blastomycosis. Ann Intern Med 1959; 51:707.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lockwood WR, Allison F Jr, Batson BE, Busey JF. The treatment of North American blastomycosis. Ten years' experience. Am Rev Respir Dis 1969; 100:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duttera MJ Jr, Osterhout S. North American blastomycosis: a survey of 63 cases. South Med J 1969; 62:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Busey JF. Blastomycosis. 3. A comparative study of 2-hydroxystilbamidine and amphotericin B therapy. Am Rev Respir Dis 1972; 105:812.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alhatem A, Smith KC. Primary Cutaneous Blastomycosis. N Engl J Med 2022; 386:e49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stead WW, Bates JH. Evidence of a "silent" bacillemia in primary tuberculosis. Ann Intern Med 1971; 74:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jennings HS 3rd, Bradsher RW, McGee ZA, et al. Acute cryptococcal cellulitis in renal transplant recipients. South Med J 1981; 74:1150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore RM, Green NE. Blastomycosis of bone. A report of six cases. J Bone Joint Surg Am 1982; 64:1097.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oppenheimer M, Embil JM, Black B, et al. Blastomycosis of bones and joints. South Med J 2007; 100:570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Güler N, Palanduz A, Ones U, et al. Progressive vertebral blastomycosis mimicking tuberculosis. Pediatr Infect Dis J 1995; 14:816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saccente M, Abernathy RS, Pappas PG, et al. Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature. Clin Infect Dis 1998; 26:413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inoshita T, Youngberg GA, Boelen LJ, Langston J. Blastomycosis presenting with prostatic involvement: report of 2 cases and review of the literature. J Urol 1983; 130:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seo R, Oyasu R, Schaeffer A. Blastomycosis of the epididymis and prostate. Urology 1997; 50:980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eickenberg H-U, Amin M, Lich R Jr. Blastomycosis of the genitourinary tract. J Urol 1975; 113:650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bariola JR, Perry P, Pappas PG, et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 2010; 50:797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dworkin MS, Duckro AN, Proia L, et al. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin Infect Dis 2005; 41:e107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemos LB, Soofi M, Amir E. Blastomycosis and pregnancy. Ann Diagn Pathol 2002; 6:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maxson S, Miller SF, Tryka AF, Schutze GE. Perinatal blastomycosis: a review. Pediatr Infect Dis J 1992; 11:760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradsher RW, Chapman SW, Pappas PG. Blastomycosis. Infect Dis Clin North Am 2003; 17:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pappas PG, Threlkeld MG, Bedsole GD, et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993; 72:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Serody JS, Mill MR, Detterbeck FC, et al. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis 1993; 16:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McBride JA, Sterkel AK, Matkovic E, et al. Clinical Manifestations and Outcomes in Immunocompetent and Immunocompromised Patients With Blastomycosis. Clin Infect Dis 2021; 72:1594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith DJ, Free RJ, Thompson Iii GR, et al. Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients with Community-Acquired Pneumonia for Primary and Urgent Care Providers. Clin Infect Dis 2023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suneja M, Beekmann SE, Dhaliwal G, et al. Diagnostic delays in infectious diseases. Diagnosis (Berl) 2022; 9:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martynowicz MA, Prakash UB. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest 2002; 121:768.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemos LB, Baliga M, Taylor BD, et al. Bronchoalveolar lavage for diagnosis of fungal disease. Five years' experience in a southern United States rural area with many blastomycosis cases. Acta Cytol 1995; 39:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stockman L, Clark KA, Hunt JM, Roberts GD. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol 1993; 31:845.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wheat LJ. Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis 2006; 8:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durkin M, Witt J, Lemonte A, et al. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004; 42:4873.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wheat J, Wheat H, Connolly P, et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997; 24:1169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kauffman CA. Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis. J Fungi (Basel) 2019; 5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarr M, Marcinak J, Mongkolrattanothai K, et al. Blastomyces antigen detection for monitoring progression of blastomycosis in a pregnant adolescent. Infect Dis Obstet Gynecol 2007; 2007:89059.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mongkolrattanothai K, Peev M, Wheat LJ, Marcinak J. Urine antigen detection of blastomycosis in pediatric patients. Pediatr Infect Dis J 2006; 25:1076.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bariola JR, Hage CA, Durkin M, et al. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis. Diagn Microbiol Infect Dis 2011; 69:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sidamonidze K, Peck MK, Perez M, et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol 2012; 50:1783.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linder KA, Kauffman CA. Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis. J Fungi (Basel) 2020; 7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995; 33:2913.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bialek R, Cirera AC, Herrmann T, et al. Nested PCR assays for detection of Blastomyces dermatitidis DNA in paraffin-embedded canine tissue. J Clin Microbiol 2003; 41:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hayden RT, Qian X, Roberts GD, Lloyd RV. In situ hybridization for the identification of yeastlike organisms in tissue section. Diagn Mol Pathol 2001; 10:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abbott JJ, Hamacher KL, Ahmed I. In situ hybridization in cutaneous deep fungal infections: a valuable diagnostic adjunct to fungal morphology and tissue cultures. J Cutan Pathol 2006; 33:426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Babady NE, Buckwalter SP, Hall L, et al. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol 2011; 49:3204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacFadden DR, Gold WL, Richardson SE, Bunce PE. A breast mass in a 56-year-old man. CMAJ 2011; 183:1875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vindenes T, Gardiner BJ, Nierenberg N, Volpe G. Pneumonia, septic arthritis, and brain abscesses in a construction worker. Clin Infect Dis 2015; 60:1722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein BS, Kuritsky JN, Chappell WA, et al. Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis. Am Rev Respir Dis 1986; 133:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein BS, Vergeront JM, Kaufman L, et al. Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. J Infect Dis 1987; 155:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradsher RW, Pappas PG. Detection of specific antibodies in human blastomycosis by enzyme immunoassay. South Med J 1995; 88:1256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sekhon AS, Kaufman L, Kobayashi GS, et al. The value of the Premier enzyme immunoassay for diagnosing Blastomyces dermatitidis infections. J Med Vet Mycol 1995; 33:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abuodeh RO, Chester EM, Scalarone GM. Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources. Mycoses 2004; 47:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sestero CM, Scalarone GM. Detection of IgG and IgM in sera from canines with blastomycosis using eight blastomyces dermatitidis yeast phase lysate antigens. Mycopathologia 2006; 162:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richer SM, Smedema ML, Durkin MM, et al. Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1. Clin Vaccine Immunol 2014; 21:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis 2021; 21:e364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradsher RW Jr. The endemic mimic: blastomycosis an illness often misdiagnosed. Trans Am Clin Climatol Assoc 2014; 125:188.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2437 Version 27.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28176377" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29878145" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20375357" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Clinical and laboratory update on blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3688635" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3317597" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11998870" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3945290" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2220880" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9313293" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Endemic blastomycosis in Mississippi: epidemiological and clinical studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26020566" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Blastomycosis in Indiana: Clinical and Epidemiologic Patterns of Disease Gleaned from a Multicenter Retrospective Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14145217" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : BLASTOMYCOSIS. I. A REVIEW OF 198 COLLECTED CASES IN VETERANS ADMINISTRATION HOSPITALS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4872945" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : North American blastomycosis: a study of 40 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Blastomycosis I: A review of the literature
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4062088" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Ketoconazole therapy for endemic blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1420675" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11981725" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26465989" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 32-2015. A 57-Year-Old Man with Severe Pneumonia and Hypoxemic Respiratory Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37286133" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : First Japanese case of disseminated blastomycosis imported from North America: A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/496107" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Canine blastomycosis as a harbinger of human disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2110723" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Pulmonary blastomycosis: findings on chest radiographs in 63 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1988756" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Roentgenologic features of pulmonary blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1988756" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Roentgenologic features of pulmonary blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3685662" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Self-limited blastomycosis: a report of 39 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8413389" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11172200" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18574291" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32227089" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Outcomes With Severe Blastomycosis and Respiratory Failure in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6478898" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The spectrum and significance of pleural disease in blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13275854" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : North American blastomycosis: a clinical study of 40 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13791477" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Clinical manifestations of pulmonary blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5820331" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The treatment of North American blastomycosis. Ten years' experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4885288" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : North American blastomycosis: a survey of 63 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5067267" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Blastomycosis. 3. A comparative study of 2-hydroxystilbamidine and amphotericin B therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35507484" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Primary Cutaneous Blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4994545" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Evidence of a "silent" bacillemia in primary tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7025237" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Acute cryptococcal cellulitis in renal transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7118980" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Blastomycosis of bone. A report of six cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17591310" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Blastomycosis of bones and joints.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8559640" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Progressive vertebral blastomycosis mimicking tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9502464" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6864904" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Blastomycosis presenting with prostatic involvement: report of 2 cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9426737" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Blastomycosis of the epididymis and prostate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1173249" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Blastomycosis of the genitourinary tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1567099" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Blastomycosis in patients with the acquired immunodeficiency syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20166817" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16288388" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The epidemiology of blastomycosis in Illinois and factors associated with death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12170451" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Blastomycosis and pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1448317" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Perinatal blastomycosis: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12751259" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8412644" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Blastomycosis in immunocompromised patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8448319" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Blastomycosis in transplant recipients: report of a case and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32179889" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Clinical Manifestations and Outcomes in Immunocompetent and Immunocompromised Patients With Blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37802909" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients with Community-Acquired Pneumonia for Primary and Urgent Care Providers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35073468" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Diagnostic delays in infectious diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11888958" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pulmonary blastomycosis: an appraisal of diagnostic techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7483983" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Bronchoalveolar lavage for diagnosis of fungal disease. Five years' experience in a southern United States rural area with many blastomycosis cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8463395" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16913971" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15472368" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Antigen assay with the potential to aid in diagnosis of blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9195077" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31323746" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17641724" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Blastomyces antigen detection for monitoring progression of blastomycosis in a pregnant adolescent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17072135" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Urine antigen detection of blastomycosis in pediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21251563" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22403418" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33383637" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8576345" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Molecular probes for diagnosis of fungal infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12517849" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Nested PCR assays for detection of Blastomyces dermatitidis DNA in paraffin-embedded canine tissue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11277390" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : In situ hybridization for the identification of yeastlike organisms in tissue section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16776718" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : In situ hybridization in cutaneous deep fungal infections: a valuable diagnostic adjunct to fungal morphology and tissue cultures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21752970" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21948717" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : A breast mass in a 56-year-old man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25972445" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Pneumonia, septic arthritis, and brain abscesses in a construction worker.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3079974" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3100658" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7502120" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Detection of specific antibodies in human blastomycosis by enzyme immunoassay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7658303" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : The value of the Premier enzyme immunoassay for diagnosing Blastomyces dermatitidis infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15078431" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16830189" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Detection of IgG and IgM in sera from canines with blastomycosis using eight blastomyces dermatitidis yeast phase lysate antigens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24285817" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34364529" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25125734" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : The endemic mimic: blastomycosis an illness often misdiagnosed.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
